Trends in Cancer Mortality in the United States and U.S. Counties From 1980 to 2014
In a study reported in JAMA, Mokdad et al found that cancer mortality rates have dropped from 240.2 to 192.0/100,000 population between 1980 and 2014. Mortality rates varied widely among U.S. counties for various cancers. The report covers 29 cancers in 3,144 counties. Summarized here are findings for tracheal/bronchus/lung, colon/rectum, breast, prostate, pancreatic, uterine, kidney, and liver cancers and non-Hodgkin lymphoma.
Study Details
The study used de-identified death records from the National Center for Health Statistics (NCHS) and population counts from the Census Bureau, the NCHS, and the Human Mortality Database from 1980 to 2014. Age-standardized mortality rates were estimated.
Overall Trend
A total of 19,511,910 cancer deaths were recorded in the United States between 1980 and 2014; mortality decreased from 240.2 to 192.0/100,000 population over this time, representing a 20.1% decrease. In 2014, the lowest rate was 70.7 in Summit County, Colorado, and the highest rate was 503.1 in Union County, Florida. In 2014, there were clusters of high mortality in several areas of the South, in Kentucky, West Virginia, Alabama, and along the Mississippi River, and in Western Alaska and counties in North and South Dakota and Texas; lower rates were observed in counties in Utah and Colorado. Significant increases in mortality were observed in 160 counties, with the highest in Kentucky and scattered regions in the South.
Tracheal, Bronchus, and Lung Cancers
- A total of 5,656,423 deaths were recorded; mortality decreased from 68.6 to 54.2/100,000, a 21.0% reduction.
- Reductions in rate were observed in the West and Northeast and Florida and increases were observed in the South, Appalachian region, and Midwest. The largest increase was observed in Owsley County, Kentucky (99.7%), and the greatest decrease in Aleutians East Borough and Aleutians West Census Area (63.6%).
- In 2014, high rates were clustered in Kentucky and West Virginia, and low rates were observed along the border with Mexico and in Utah, Colorado, and parts of Arizona, New Mexico, and Idaho. Rates varied from 10.6 in Summit County, Colorado, to 334.9/100,000 in Union County, Florida, for males and from 10.9 in Summit County, Colorado, to 121/100,000 in Owsley County, Kentucky, for females.
Colon and Rectal Cancers
- A total of 2,484,476 deaths were recorded; the rate dropped from 34.3 to 22.1/100,000, a 35.5% decrease. The greatest decrease occurred since 2001.
- In 2014, the highest rate was in Union County, Florida (58.4/100,000), and the lowest rate was in Summit County, Colorado (8.1/100,000). High-rate clusters were found along the Mississippi River in Missouri, Mississippi, Arkansas, and Louisiana, with others in southern Alabama, Alaska, and along the border of West Virginia and Kentucky. High rates were also found in counties in Nevada, North and South Dakota, and Montana.
- Significant declines were observed in 2,420 counties, with the greatest in Howard County, Maryland (64.2%), and Nassau County, New York (62.3%).
Breast Cancer
- A total of 1,573,593 deaths were recorded; the rate dropped from 21.2 to 14.3/100,000, a 32.7% reduction.
- The largest decreases were observed in the Northeast, southern Florida, and parts of the northern Midwest. Significant declines were observed in 1,910 counties, with the greatest observed in Summit County, Colorado (55.3%), and Nassau County, New York (54.9%).
- In 2014, rates ranged from 11.3 in Summit County, Colorado, to 51.8/100,000 in Madison County, Mississippi. High rate clusters were found in the southern belt and along the Mississippi River. Lower rates were found in parts of the West, Midwest, and Northeast.
Prostate Cancer
- A total of 1,077,030 deaths were recorded; the rate dropped from 13.0 to 10.2/100,000, a 21.7% decrease.
- Significant reductions in rates were observed in 1,558 counties, with changes ranging from a 69.4% decrease in Aleutians East Borough and Aleutians West Census Area to a 26.1% increase in Owsley County, Kentucky.
- In 2014, rates varied from 10.0 in Summit County, Colorado, to 64.1/100,000 in Madison County, Mississippi. High-cluster patterns similar to those found for breast cancer were present in the southern belt and along the Mississippi River, with counties in Alabama, Georgia, South Carolina, and Virginia also having high rates. Lower rates were found in counties in southern Florida and along the U.S. border with Mexico.
Pancreatic Cancer
- A total of 1,157,878 deaths were recorded; the rate dropped from 13.0 to 12.8/100,000, a 1.8% decrease.
- Changes ranged from an increase of 51.7% in Union County, Florida, to a decrease of 46.2% in Aleutians East Borough and Aleutians West Census Area. Increases were found throughout the country, with clusters of larger increases in Kentucky, Kansas, and northeastern Pennsylvania. Decreased rates were found in southern Texas, California, and the Dakotas.
- In 2014, rates were lowest in counties in Colorado, Florida, Arizona, and two regions in Texas and highest in the South along the Mississippi River delta and in counties in Alabama, Georgia, North and South Carolina, Virginia, and Kentucky.
Uterine Cancer
- A total of 209,314 deaths were recorded; rates declined from 2.5 to 2.1/100,000, a 16.1% decrease. Declines were not steady.
- Larger declines were found in many counties in California, Colorado, Nevada, and Arkansas, whereas increasing rates were found in clusters in northern Maine, Iowa, Texas, the Carolinas, Virginia, and West Virginia. In 2014, the highest rates were found in these regions, and high rates were also found in counties in Montana, New Hampshire, and Vermont.
Kidney Cancer
- A total of 421,628 deaths were recorded; rates were unchanged at approximately 4.6/100,000.
- Decreased rates were found in the Northeast and in southern Florida, whereas increases were seen in a wide zone, including most counties in the South and Midwest, as well as in the Pacific Northwest and Utah.
- In 2014, rates ranged from 2.1 in Summit County, Colorado, to 9.7/100,000 in Buffalo County, South Dakota. Counties in Colorado and south Florida had very low rates, whereas clusters of high rates were found along the Mississippi Delta, Oklahoma, Texas, North and South Dakota, and counties in West Virginia, Ohio, Indiana, Illinois, Alaska, and some counties with large Native American populations in South Dakota, North Dakota, and the Four Corners area.
Liver Cancer
- A total of 487,518 deaths were recorded; rates increased from 3.6 to 6.8/100,000, an increase of 87.6%.
- In 2014, rates ranged from 2.3 in Summit County, Colorado, to 37.6/100,000 in Anderson County, Texas. Almost all counties (3,069) had significant increases in death rates, with many counties on the West Coast and in New Mexico and West Texas having very large increases. High rates were found in a cluster of counties along the Mexico border in Texas and in counties with large Native American populations in South Dakota, New Mexico, and Alaska.
Non-Hodgkin Lymphoma
- A total of 829,396 deaths were recorded; mortality rates were unchanged at 8.3/100,000.
- Rates increased markedly in a cluster of counties in West Virginia and eastern Kentucky and in a belt of counties from Alabama through South Carolina, whereas declining rates were observed in many counties in New England, Nevada, California, Florida, and Alaska. In 2014, low rates were found in the Four Corners area, Alaska, and some counties on the Texas-Mexico border. Higher rates were found throughout the Midwest, with especially high rates in southern Louisiana, Michigan, Iowa, the Appalachian region, Indiana, Ohio, and Pennsylvania.
The investigators concluded: “Cancer mortality declined overall in the United States between 1980 and 2014. Over this same period, there were important changes in trends, patterns, and differences in cancer mortality among US counties. These patterns may inform further research into improving prevention and treatment.”
The study was funded by the Robert Wood Johnson Foundation, the National Institute on Aging, John W. Stanton, and Theresa E. Gillespie.
Christopher J.L. Murray, MD, DPhil, of the University of Washington Institute for Health Metrics and Evaluation, is the corresponding author of the JAMA article.
The content in this post has not been reviewed by the American Society of Clinical Oncology, Inc. (ASCO®) and does not necessarily reflect the ideas and opinions of ASCO®.
